Milestone Scientific, Inc. (MLSS) News
Filter MLSS News Items
MLSS News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
MLSS News Highlights
- For MLSS, its 30 day story count is now at 2.
- Over the past 5 days, the trend for MLSS's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- FOLD are the most mentioned tickers in articles about MLSS.
Latest MLSS News From Around the Web
Below are the latest news stories about Milestone Scientific Inc that investors may wish to consider to help them evaluate MLSS as an investment opportunity.
Milestone Scientific Reports Fourteen-Fold Increase in Revenue for Second Quarter of 2021ROSELAND, N.J., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the second quarter ended June 30, 2021. Arjan Haverhals, President and Chief Executive Officer of Milestone Scientific, commented, “We achieved a fourteen-fold increase in revenue to $2.4 million versus $168,000 for the same period la |
Milestone Scientific Schedules Second Quarter 2021 Business Update Conference CallROSELAND, N.J., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced it will host a conference call at 11:00 A.M. Eastern Time on Monday, August 16, 2021 to discuss the Company’s financial results for the second quarter ended June 30, 2021, as well as the Company’s corporate progress and other developments. The conference call will b |
Milestone Scientific, Inc. (MLSS) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseMilestone Scientific, Inc. (MLSS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
Milestone Scientific Commences Sales of CompuFlo® / CathCheck™ Disposables within the UTMB Health Clear Lake Campus HospitalAgreement represents second hospital within the UTMB Health networkROSELAND, N.J., July 07, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today reported that the University of Texas Medical Branch (UTMB) Health Clear Lake Campus Hospital has begun use of the CompuFlo® Epidural Instrument. UTMB is an institution of the University of Texas System and agency of the State of |
Implied Volatility Surging for Milestone Scientific (MLSS) Stock OptionsInvestors need to pay close attention to Milestone Scientific (MLSS) stock based on the movements in the options market lately. |
Milestone Scientific, Inc. (MLSS) Moves to Buy: Rationale Behind the UpgradeMilestone Scientific, Inc. (MLSS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). |
Milestone Scientific Expands Medical Sales Team to Capitalize on Growing Interest in CompuFlo Including Appointment of Senior Industry Sales Executive Chet Trechock as VP of Sales for MedicalROSELAND, N.J., June 23, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has expanded its medical sales team including the appointment of Chet Trechock as VP of Sales Medical. Arjan Haverhals, CEO of Milestone Scientific, stated, "We are witnessing growing interest in our CompuFlo® Epidural Instrument and CathCheck™ System among anesthesiologists an |
Milestone Scientific Schedules 2020 Year-End Business Update Conference CallROSELAND, N.J., March 30, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced it will host a conference call at 4:30 p.m. Eastern Time on Thursday, April 1, 2021 to discuss the Company’s financial results for the full year ending December 31, 2020, as well as the Company’s corporate progress and other developments. The conference call will be available via telephone by dialing toll free 1- 877-407-0778 for U.S. callers or 201-689-8565 for international callers. A webcast of the call may be accessed here or on the Company’s website at https://www.milestonescientific.com/. An audio replay of the of the call will be available through A... |
Milestone Scientific, Inc. (MLSS) May Report Negative Earnings: Know the Trend Ahead of Q4 ReleaseMilestone Scientific, Inc. (MLSS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
Milestone Scientific to Present at the Q1 Virtual Investor SummitROSELAND, N.J., March 12, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced that Arjan Haverhals, CEO of Wand Dental and President of Milestone Scientific, will be presenting at the Q1 Virtual Investor Summit on March 24th. Event Q1 Investor SummitDateMarch 23-25th, 2021Presentation March 24th @ 11:00AM ETLocationhttps://zoom.us/webinar/register/WN_zq3yW7kuQouOPE28oFuSvw About The Investor SummitThe Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q1 Investor Summit will take place virtually, featu... |